ClinicalTrials.gov
ClinicalTrials.gov Menu

Immediate Maintained Cannulation of a Newly Implanted Prosthetic Arteriovenous Access for Acute Hemodialysis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00711750
Recruitment Status : Unknown
Verified July 2008 by Far Eastern Memorial Hospital.
Recruitment status was:  Recruiting
First Posted : July 9, 2008
Last Update Posted : July 9, 2008
Sponsor:
Information provided by:
Far Eastern Memorial Hospital

Brief Summary:
Objectives: Examine the acute utility of immediate maintained cannulations of a newly implanted prosthetic arteriovenous access. Background: Recurrent failure of central catheterization is not uncommon. An alternative access is necessary for acute hemodialysis after the exhaustion of central veins. Methods: We constructed the access by cannulating two dialysis needle-catheters and securing them on the skin after the implantation of the graft. The access was used immediately and maintained for one week and thereafter used as a long-term access.

Condition or disease
End-Stage Renal Disease Prosthetic Arteriovenous Access

Study Type : Observational
Estimated Enrollment : 39 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Study Start Date : January 2008




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with end-stage renal disease underwent the specific prosthetic arteriovenous access creation in our hospital from November 2003 to October 2005 were retrospectively reviewed.
Criteria

Inclusion Criteria:

  • end-stage renal disease underwent the specific prosthetic arteriovenous access creation in our hospital from November 2003 to October 2005

Exclusion Criteria:

  • patients' poor health as long as they did not have other options and needed an access for acute hemodialysis. Exclusions included shock, active systemic infection, and rejection by the attending nephrologists

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00711750


Contacts
Contact: Chih-Yang Chan, MD, PhD 886-89667000 chanchihyang@mail.femh.org.tw

Locations
Taiwan
Far Eastern Memorial Hospital Recruiting
Taipei, Taiwan
Contact: Chih-Yang Chan, MD, PhD    886-89667000    chanchihyang@mail.femh.org.tw   
Sponsors and Collaborators
Far Eastern Memorial Hospital

Responsible Party: Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT00711750     History of Changes
Other Study ID Numbers: FEMH-96042
First Posted: July 9, 2008    Key Record Dates
Last Update Posted: July 9, 2008
Last Verified: July 2008

Keywords provided by Far Eastern Memorial Hospital:
underwent
specific
creation
hospital
November 2003
October 2005

Additional relevant MeSH terms:
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases